The Silent Revolution
Twenty years of transformation in anti-cancer therapies — and why nuclear medicine is at the heart of the convergence
Artificial intelligence in nuclear medicine
Diagnostic support, image enhancement and reporting assistance. A concrete and measured overview of current AI applications in our specialty, in light of 2024–2026 publications.
The rise of PET imaging: twenty years of transformation in oncology
From a last-resort modality to decision-driving imaging, PET has profoundly reshaped diagnostic, prognostic and theranostic standards in cancer care.
Beyond cancer: biomarkers open a new era for PET
Cognitive impairment, breathlessness or persistent inflammation: similar symptoms may reflect different biological mechanisms. Identifying them becomes essential as treatments become more specialised. Positron emission tomography — PET — contributes to this approach beyond oncology. By locating a target or measuring a function, it connects biology with the affected organ. New radiotracers are expanding this approach, although their levels of validation still vary considerably.